Trans-catheter valve-in-valve (ViV) is a treatment option for patients affected by bioprosthetic heart valve (BHV) failure. Both aortic and mitral ViV procedures present several challenges compared to native valve replacement. To date, no data concerning the balloon-expandable MyVal (Meril, Vapi, India) trans-catheter heart valve (THV) use in ViV procedure have been provided. In this case series, we described for the first time its use in five different BHV failures.
Keywords: Aortic bioprosthesis; Balloon-expandable trans-catheter heart valve; Bioprosthetic heart valve; Mitral bioprosthesis; Trans-catheter aortic valve implantation; Valve-in-valve.
Copyright © 2020 Elsevier Inc. All rights reserved.